Evidence for Pro-Inflammatory Activity of LTα3 on Macrophages: Significance for Experimental Arthritis and for Therapeutic Switching in Rheumatoid Arthritis Patients
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136355 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ariane Benezech und 8 weiteren Autor:innen. Beteiligte Einrichtung: INSERM U1043, Centre de Physiopathologie de Toulouse Purpan, 31059 Toulouse, France. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Macrophages, Arthritis, Experimental, Lymphotoxin-alpha. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MSD-AVENIR, Région Occitanie, MSD-AVENIR (“Bioric”), Région Occitanie: (“Prematuration Program”).
Abstract (Originalsprache)
Lymphotoxin-alpha (LTα3) is a soluble cytokine of the TNF superfamily. Its role in inflammation and arthritis is not well known. Macrophages are important in K/BxN Serum-Transfer Arthritis (STA) and rheumatoid arthritis (RA). Anti-TNF monoclonal antibodies as well as etanercept (ETA), a soluble TNF receptor II that also neutralizes LTα3, are efficient in the treatment of RA.
Objectives
To evaluate the role of LTα3 in macrophage phenotypes and in arthritis.
Methods
Macrophages were cultured in the presence of recombinant LTα3, and their phenotypes were studied. The clinical effect of blocking LTα3 in STA was evaluated, as well as the effect of switching from anti-TNF monoclonal antibodies to etanercept in the “ROC” register of RA patients.
Results
We showed that recombinant LTα3 was capable of directing mouse and human macrophages towards a pro-inflammatory “M1” phenotype. In K/BxN STA, ETA decreased clinical score and joint swelling. Anti-LTα3 reduced arthritis only in TNF-KO mice, indicating that the effect of LTα3 was visible in the absence of TNF. The “ROC” register indicated that switching anti-TNF mAb to ETA did not induce clinical and biological improvement in RA.
Conclusion
We show a pro-inflammatory role for LTα3 in murine and human macrophages. The neutralization of both TNF and LTα3 is not beneficial in the treatment of RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- INSERM U1043, Centre de Physiopathologie de Toulouse Purpan, 31059 Toulouse, France.
- Service de Rhumatologie, CHU de Strasbourg, 67098 Strasbourg, France.
- Centre de Rhumatologie, CHU de Toulouse, 31059 Toulouse, France.
- Deutsches Rheuma-Forschungszentrum, 10117 Berlin, Germany.
- Genentech, San Francisco, CA 94080, USA.
- Inserm UMR 1027, CHU Purpan, 31062 Toulouse, France.
ORCID-Profile: Andrey Kruglov, Fabienne Briand-Mésange, Alain Cantagrel
Förderung
- MSD-AVENIR, Région Occitanie
- MSD-AVENIR (“Bioric”)
- Région Occitanie: (“Prematuration Program”)
Zitieren
APA
Benezech, A., Gottenberg, J. E., Degboé, Y., Kruglov, A., Grogan, J., Briand-Mésange, F., Cantagrel, A., Ruyssen-Witrand, A., & Davignon, J. L. (2025). Evidence for Pro-Inflammatory Activity of LTα3 on Macrophages: Significance for Experimental Arthritis and for Therapeutic Switching in Rheumatoid Arthritis Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136355
Vancouver
Benezech A, Gottenberg JE, Degboé Y, Kruglov A, Grogan J, Briand-Mésange F, et al. Evidence for Pro-Inflammatory Activity of LTα3 on Macrophages: Significance for Experimental Arthritis and for Therapeutic Switching in Rheumatoid Arthritis Patients. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136355
BibTeX
@article{Benezech2025,
author = {Benezech, Ariane and Gottenberg, Jacques-Eric and Degboé, Yannick and Kruglov, Andrey and Grogan, Jane and Briand-Mésange, Fabienne and Cantagrel, Alain and Ruyssen-Witrand, Adeline and Davignon, Jean-Luc},
title = {Evidence for Pro-Inflammatory Activity of LTα3 on Macrophages: Significance for Experimental Arthritis and for Therapeutic Switching in Rheumatoid Arthritis Patients},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136355}
}
EUVIMED